Journal Club

 

2020

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents30.03.2020 (Matthias von Rotz)
Kampf G. et al.: Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents Journal of Hospital Infection 104 246-251 2020
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study10.02.2020 (Sabine Kuster)
Nashan Chen et al.: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet Infectious Disease Published Online January 29, 2020 1-7 2020
Β-Lactam pharmacodynamics in Gram-negative bloodstream infections in
critically ill
06.01.2020 (Sandra Zingg)
Gloria Wong: Β-Lactam pharmacodynamics in Gram-negative bloodstream infections in critically ill J Antimicrob Chemother 75 429-433 2020
Fosfomycin for Injection (ZTI-01) Versus PiperacillinPiperacillintazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial20.01.2020 (Elisabeth Wehrle)
Kaye K.: Fosfomycin for Injection (ZTI-01) Versus PiperacillinPiperacillintazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial CID 69 2045-2056 2019
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis oft wo randomised controlled trials13. 01.2020 (Mihaela Sava)
Campbell R J. et al.: Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis oft wo randomised controlled trials Lancet Infect Dis 2019 Online First 2019